Skip to main content

Advertisement

Log in

Lymph Node Ratio: Role in the Staging of Node-Positive Colon Cancer

  • Gastrointestinal Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Recent literature has shown that lymph node ratio (LNR) is superior to the number of positive lymph nodes (pLNs) in predicting the prognosis in several malignances other than colon cancer. We hypothesize that LNR may play a similar role in stage III colon cancer.

Methods

We included 24,477 stage III colon cancer cases from the Surveillance, Epidemiology, and End Results cancer registry. Patients were categorized into four groups, LNR1 to 4, according to cutoff points \( \raise0.5ex\hbox{$\scriptstyle 1$} \kern-0.1em/\kern-0.15em \lower0.25ex\hbox{$\scriptstyle {14}$} \), 0.25, and 0.50. Kaplan-Meier and Cox proportional hazard model were used to evaluate the prognostic effect and estimate the relative risk (RR) and 95% confidence interval (CI) of LNR.

Results

The 5-year survival for patients with stage IIIA, IIIB, and IIIC was 71.3%, 51.7%, and 34.0%, respectively (P < .0001). There was no survival difference among LNR1 to LNR4 for stage IIIA patients. In stage IIIB patients, the 5-year survival for those with LNR1 to LNR4 was 63.5%, 54.7%, 44.4%, and 34.2%, respectively (P < .0001). In stage IIIC patients, the 5-year survival for those with LNR2 to LNR4 was 49.6%, 41.7%, and 25.2%, respectively (P < .0001). LNR is an independent predictor of survival after adjusting patient’s age, tumor size, tumor grade, race, number of pLNs, and total number of LNs harvested. (RR 2.30, 95% CI 2.08–2.55).

Conclusion

Patients with stage IIIB and IIIC colon cancer represent a heterogeneous group of patients with the majority either overstaged or understaged. LNR is a more accurate prognostic method for stage III colon cancer patients. We propose an algorithm to incorporate LNR into current AJCC staging system.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

FIG. 1.
FIG. 2.
FIG. 3.
FIG. 4.

Similar content being viewed by others

References

  1. National Comprehensive Cancer Network Website: http://www.nccn.org/patients/patient_gls/_english/_colon/1_introduction.asp

  2. Hutter RVP. At last: worldwide agreement on the staging of cancer. Arch Surg 1987; 122:1235–9

    PubMed  CAS  Google Scholar 

  3. AJCC Cancer Staging Manual, 6th ed. New York: Springer, 2002

  4. Greene FL, Stewart AK, Norton J. A new TNM staging strategy for node-positive (stage III) colon cancer: An analysis of 50,042 patients. Ann Surg 2002; 236:416–21

    Article  PubMed  Google Scholar 

  5. Berger AC, Sigurdson ER, LeVoyer T, et al. Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. J Clin Oncol 2005; 23:8706–12

    Article  PubMed  Google Scholar 

  6. Yu W, Choi GS, Wang I, et al. Comparison of five systems for staging lymph node metastasis in gastric cancer. Br J Surg 1997; 84:1305–9

    Article  PubMed  CAS  Google Scholar 

  7. Kodera Y, Yamamura Y, Shimizu Y, et al. Lymph node status assessment for gastric carcinoma: is the number of metastatic lymph nodes really practical as a parameter for N categories in the TNM classification? J Surg Oncol 1998; 69:15–20

    Article  PubMed  CAS  Google Scholar 

  8. Siewert JR, Bottcher FK, Stein HJ, et al. Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. Ann Surg 1998; 228:449–61

    Article  PubMed  CAS  Google Scholar 

  9. Inoue K, Nakane Y, Liyama H, et al. The superiority of ratio-based lymph node staging in gastric carcinoma. Ann Surg Oncol 2002; 9:27–34

    Article  PubMed  Google Scholar 

  10. van der Wal BC, Butzelaar RM, van der Meij S, et al. Axillary lymph node ratio and total number of removed lymph nodes: Predictors of survival in stage I and II breast cancer. Eur J Surg Oncol 2002; 28:481–9

    Article  PubMed  Google Scholar 

  11. Megale Costa LJ, Soares HP, Gaspar HA, et al. Ratio between positive lymph nodes and total dissected axillaries lymph nodes as an independent prognostic factor for disease-free survival in patients with breast cancer. Am J Clin Oncol 2004; 27:304–6

    Article  PubMed  Google Scholar 

  12. Vinh-Hung V, Verschraegen C, Promish DI, et al. Ratios of involved nodes in early breast cancer. Breast Cancer Res 2004; 6:R680–8

    Article  PubMed  Google Scholar 

  13. Voordeckers M, Vinh-Hung V, Van de Steene J, et al. The lymph node ratio as prognostic factor in node-positive breast cancer. Radiother Oncol 2004; 70:225–30

    Article  PubMed  Google Scholar 

  14. Truong PT, Berthelet E, Lee J, et al. Prognostic significance of the percentage of positive/dissected axillary nodes in breast cancer relapse and survival in patients with 1–3 positive axillary nodes. Cancer 2005; 103:2006–14

    Article  PubMed  Google Scholar 

  15. Woodward WA, Vinh-Hung V, Ueno NT, et al. Prognostic value of nodal ratios in node-positive breast cancer. J Clin Oncol 2006; 24:2910–6

    Article  PubMed  Google Scholar 

  16. De Ridder M, Vinh-Hung V, Van Nieuwenhove Y, et al. Prognostic value of the lymph node ratio in node positive colon cancer. Gut 2006; 55:1681

    Article  PubMed  Google Scholar 

  17. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53:457–81

    Article  Google Scholar 

  18. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143:29–36

    PubMed  CAS  Google Scholar 

  19. Cox DR. Regression models and life tables. J R Stat Soc B 1972; 34:187–220

    Google Scholar 

  20. Chang GJ, Rodriguez-Bigas MA, Skibber JM, et al. Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst 2007; 99:433–41

    Article  PubMed  Google Scholar 

  21. Marchet A, Mocellin S, Ambrosi A, et al. The ratio between metastasis and examined lymph nodes (N ratio) is an independent prognostic factor in gastric cancer regardless of the type of lymphadenectomy: results from an Italian multicentric study in 1853 patients. Ann Surg 2007; 245:543–52

    Article  PubMed  Google Scholar 

  22. Walker MJ, Osborne MD, Young DC, et al: The natural history of breast cancer with more than 10 positive nodes. Am J Surg 1995; 169:575–9

    Article  PubMed  CAS  Google Scholar 

  23. Gurkaynay M, Yildiz F, Atahan L. T3N0M0 breast cancer patients: A subgroup with favorable prognosis. Turkish J. Cancer 2003; 33:144–9

    Google Scholar 

  24. Wong JH, Severino R, Honnerbier MB, et al. Number of nodes examined and staging accuracy in colorectal carcinoma. J Clin Oncol 1999; 17:2896–900

    PubMed  CAS  Google Scholar 

  25. Wong JH, Johnson DS, Hemmings D, et al. Assessing the quality of colorectal cancer staging: documenting the process in improving the staging of node negative cororectal cancer. Arch Surg 2005; 140:881–6

    Article  PubMed  Google Scholar 

  26. Swanson RS, Compton CC, Stewart AK, Bland KI. The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined. Ann Surg Oncol 2003; 10:65–71

    Article  PubMed  Google Scholar 

  27. Tepper JE, O’Connell MJ, Niedzwiecki D, et al. Impact of number of nodes retrieved on outcome in patients with rectal cancer. J Clin Oncol 2001;19:157–63

    PubMed  CAS  Google Scholar 

  28. Compton C, Fenoglio-Preiser CM, Pettigrew N, et al. American Joint Committee on Cancer Prognostic Factors Consensus Conference: Colorectal Working Group. Cancer 2000; 88:1739–57

    Article  PubMed  CAS  Google Scholar 

  29. Yarbro JW, Page DL, Fielding LP, et al. American Joint Committee on Cancer prognostic factors consensus conference. Cancer 1999; 86:2436–46

    Article  PubMed  CAS  Google Scholar 

  30. Goldstein NS, Weldon S, Coffey M, et al. Lymph node recovery from colorectal resection specimens removed from adenocarcinoma: Trends over time and a recommendation for a minimum number of lymph nodes to be recovered. Am J Clin Pathol 1996; 106:209–16

    PubMed  CAS  Google Scholar 

  31. Kim J, Huynh R, Abraham I, et al. Number of lymph nodes examined and its impact on colorectal cancer staging. Am Surg 2006; 72:902–5

    PubMed  Google Scholar 

  32. Berberoglu U. Prognostic significance of total lymph node number in patients with T1–4N0M0 colorectal cancer. Hepatogastroenterology 2004; 51:1689–93

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jiping Wang MD, PhD.

Additional information

Published by Springer Science+Business Media, Inc. © 2007 The Society of Surgical Oncology, Inc.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, J., Hassett, J.M., Dayton, M.T. et al. Lymph Node Ratio: Role in the Staging of Node-Positive Colon Cancer. Ann Surg Oncol 15, 1600–1608 (2008). https://doi.org/10.1245/s10434-007-9716-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-007-9716-x

Keywords

Navigation